Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-09-08 Sale | 2025-09-09 6:37 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 871 | $19.11 | $16,645 | 150,692 (Direct) | View |
| 2025-09-08 Sale | 2025-09-09 6:32 pm | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 1,520 | $19.11 | $29,047 | 46,639 (Direct) | View |
| 2025-08-11 Sale | 2025-08-13 09:58 am | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 10,000 | $17.69 | $176,900 | 148,229 (Direct) | View |
| 2025-07-28 Sale | 2025-07-30 4:03 pm | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 7,522 | $19.14 | $143,971 | 41,492 (Direct) | View |
| 2025-07-28 Sale | 2025-07-30 4:02 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 5,149 | $19.14 | $98,552 | 158,229 (Direct) | View |
| 2025-06-09 Sale | 2025-06-11 09:14 am | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 5,162 | $7.37 | $38,044 | 163,378 (Direct) | View |
| 2025-01-31 Sale | 2025-02-04 11:53 am | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 4,551 | $11.14 | $50,698 | 178,541 (Direct) | View |
| 2025-01-31 Sale | 2025-02-04 11:51 am | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 7,379 | $11.14 | $82,202 | 60,181 (Direct) | View |
| 2024-09-09 Sale | 2024-09-12 1:54 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 859 | $13.08 | $11,236 | 148,425 (Direct) | View |
| 2024-09-09 Sale | 2024-09-12 1:51 pm | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 1,521 | $13.08 | $19,895 | 31,893 (Direct) | View |
| 2024-06-10 Sale | 2024-06-11 1:15 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 5,153 | $13.08 | $67,401 | 164,284 (Direct) | View |
| 2024-03-18 Sale | 2024-03-20 4:38 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 12,000 | $14.05 | $168,600 | 139,437 (Direct) | View |
| 2024-02-01 Sale(A) | 2024-02-05 9:16 pm | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 4,993 | $15.78 | $78,790 | 23,414 (Direct) | View |
| 2024-02-01 Sale(A) | 2024-02-05 9:15 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 3,789 | $15.78 | $59,790 | 151,437 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:12 pm | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 4,993 | $15.74 | $78,590 | 55,748 (Direct) | View |
| 2024-01-31 Sale | 2024-02-02 7:07 pm | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 3,789 | $15.74 | $59,639 | 169,438 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-09-07 Exercise | 2025-09-09 6:37 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,667 | $0 | 150,692 (Direct) | View |
| 2025-09-07 Exercise | 2025-09-09 6:32 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 3,333 | $0 | 46,639 (Direct) | View |
| 2025-08-26 Option Award | 2025-08-27 4:39 pm | N/A 2035-08-26 | UroGen Pharma Ltd. | URGN | Wildman Daniel George Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2025-08-26 Option Award | 2025-08-27 4:39 pm | N/A 2035-08-26 | UroGen Pharma Ltd. | URGN | Robinson James A. Jr. Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2025-08-26 Option Award | 2025-08-27 4:38 pm | N/A 2035-08-26 | UroGen Pharma Ltd. | URGN | Holden Stuart Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2025-08-26 Option Award | 2025-08-27 4:37 pm | N/A 2035-08-26 | UroGen Pharma Ltd. | URGN | BUTITTA CYNTHIA M Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2025-08-26 Option Award | 2025-08-27 4:37 pm | N/A 2035-08-26 | UroGen Pharma Ltd. | URGN | WEN LEANA Director | 18,000 | $0 | 18,000 (Direct) | View |
| 2025-08-26 Option Award | 2025-08-27 4:36 pm | N/A 2035-08-26 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2025-07-28 Option Award | 2025-07-30 4:08 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 87,615 | $0 | 87,615 (Direct) | View |
| 2025-07-28 Exercise | 2025-07-30 4:03 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 16,500 | $0 | 41,492 (Direct) | View |
| 2025-07-28 Exercise | 2025-07-30 4:02 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 10,000 | $0 | 158,229 (Direct) | View |
| 2025-06-08 Exercise | 2025-06-11 09:14 am | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 10,000 | $0 | 163,378 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 11:53 am | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 20,000 | $0 | 178,541 (Direct) | View |
| 2025-01-31 Exercise | 2025-02-04 11:53 am | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 8,000 | $0 | 178,541 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 11:51 am | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 10,000 | $0 | 60,181 (Direct) | View |
| 2025-01-31 Exercise | 2025-02-04 11:51 am | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 14,667 | $0 | 60,181 (Direct) | View |
| 2025-01-31 Option Award | 2025-02-04 11:49 am | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 96,377 | $0 | 96,377 (Direct) | View |
| 2024-10-08 Option Award | 2024-10-09 4:22 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Degnan Chris Chief Financial Officer | 87,592 | $0 | 87,592 (Direct) | View |
| 2024-09-09 Exercise | 2024-09-12 1:54 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 1,666 | $0 | 148,425 (Direct) | View |
| 2024-09-09 Exercise | 2024-09-12 1:51 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 3,333 | $0 | 31,893 (Direct) | View |
| 2024-09-09 Exercise | 2024-09-12 1:50 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer | 2,500 | $0 | 42,753 (Direct) | View |
| 2024-08-06 Option Award | 2024-08-08 09:11 am | N/A 2034-08-06 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-08-06 Option Award | 2024-08-08 09:11 am | N/A 2034-08-06 | UroGen Pharma Ltd. | URGN | Cohen Fred E Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-08-06 Option Award | 2024-08-08 09:10 am | N/A 2034-08-06 | UroGen Pharma Ltd. | URGN | Wildman Daniel George Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-08-06 Option Award | 2024-08-08 09:09 am | N/A 2034-08-06 | UroGen Pharma Ltd. | URGN | Holden Stuart Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-08-06 Option Award | 2024-08-08 09:08 am | N/A 2034-08-06 | UroGen Pharma Ltd. | URGN | Robinson James A. Jr. Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-08-06 Option Award | 2024-08-08 09:07 am | N/A 2034-08-06 | UroGen Pharma Ltd. | URGN | WEN LEANA Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-08-06 Option Award | 2024-08-08 09:06 am | N/A 2034-08-06 | UroGen Pharma Ltd. | URGN | BUTITTA CYNTHIA M Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2024-06-10 Exercise | 2024-06-11 1:15 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 10,000 | $0 | 164,284 (Direct) | View |
| 2024-01-31 Exercise(A) | 2024-02-12 5:47 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer | 3,333 | $0 | 35,253 (Direct) | View |
| 2022-03-25 Option Award(A) | 2024-02-12 5:43 pm | N/A 2032-03-25 | UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer | 20,000 | $0 | 20,000 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 7:12 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 16,500 | $0 | 55,748 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 7:12 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Smith Jason Drew General Counsel | 10,000 | $0 | 55,748 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 7:07 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 10,000 | $0 | 169,438 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 7:07 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Schoenberg Mark Chief Medical Officer | 6,666 | $0 | 169,438 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 7:05 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer | 12,000 | $0 | 45,252 (Direct) | View |
| 2024-01-31 Exercise | 2024-02-02 7:05 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Kim Dong Chief Financial Officer | 3,333 | $0 | 45,252 (Direct) | View |
| 2024-01-31 Option Award | 2024-02-02 7:04 pm | N/A N/A | UroGen Pharma Ltd. | URGN | Barrett Elizabeth A. Chief Executive Officer | 87,615 | $0 | 87,615 (Direct) | View |
| 2023-09-07 Option Award | 2023-09-08 3:43 pm | N/A 2033-09-07 | UroGen Pharma Ltd. | URGN | Belldegrun Arie Director | 10,000 | $0 | 10,000 (Direct) | View |
| 2023-09-07 Option Award | 2023-09-08 3:43 pm | N/A 2033-09-07 | UroGen Pharma Ltd. | URGN | BUTITTA CYNTHIA M Director | 10,000 | $0 | 10,000 (Direct) | View |